China Biologic Products Inc., of Beijing, said it priced a follow-on offering of about 1.6 million shares of common stock at a price of $38 per share. Of those, the company will be offering 800,000 shares for gross proceeds of about $30.4 million. The remaining 750,000 shares will be sold by a company stockholder, and China Biologic will not receive any of those proceeds.